Organization profile
Organization profile
A unit of the Academic Health Center, Molecular and Cellular Therapeutics offers state-of-the-art GMP/GTP compliant, full-service development and manufacturing of cell- and tissue-based products, monoclonal antibodies and other therapeutic proteins, as well as active pharmaceutical ingredients, for use in Phase I, II or III clinical trials. Our fully-staffed technical and quality personnel with over 70 years of combined cell-based products experience, through product development and technical expertise, as well as medical and regulatory support, work to compress development timelines and translate research into medicine.
UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. Our work contributes towards the following SDG(s):
-
SDG 3 Good Health and Well-being -
SDG 4 Quality Education -
SDG 9 Industry, Innovation, and Infrastructure
Fingerprint
Collaborations and top research areas from the last five years
Profiles
-
Diane M Kadidlo
- Molecular and Cellular Therapeutics - Research Director
- Office of Academic Clinical Affairs
Person: Research Support
-
-
-
-
PACT - Preclinical development of PB-drevived iTregs
McKenna, D. H. (PI)
NIH NATL HEART, LUNG AND BLOOD INSTITU
11/1/19 → 3/31/22
Project: Research project
-
Clinical manufacture of CRISPR/Cas9-based cytokine-induced SH2 protein knock-out tumor-infiltrating lymphocytes for gastrointestinal cancers
Johnson, M. J., Sumstad, D., Folsom, T. D., Slipek, N. J., DeFeo, A. P., Growe, M., Kadidlo, D., Thyagarajan, B., Starr, T. K., Lou, E., Choudhry, M., Moriarity, B. S., Webber, B. R. & McKenna, D. H., Oct 2025, In: Cytotherapy. 27, 10, p. 1229-1239 11 p.Research output: Contribution to journal › Article › peer-review
4 Link opens in a new tab Scopus citations -
Comparative transcriptomics reveals a mixed basal, club, and hillock epithelial cell identity in castration-resistant prostate cancer
Pitzen, S. P., Rudenick, A. N., Qiu, Y., Zhang, W., Munro, S. A., McCluskey, B. M., Forster, C., Bergom, H. E., Ali, A., Boytim, E., Lafin, J. T., Linder, S., Ismail, M., Devlies, W., Sessions, C. J., Claessens, F., Joniau, S., Attard, G., Zwart, W. & Nelson, P. S. & 10 others, , Feb 11 2025, In: Proceedings of the National Academy of Sciences of the United States of America. 122, 6, p. e2415308122 e2415308122.Research output: Contribution to journal › Article › peer-review
Open Access6 Link opens in a new tab Scopus citations -
Preclinical quality, safety, and efficacy of a CGMP iPSC-derived myogenic progenitor product for the treatment of muscular dystrophies
Azzag, K., Magli, A., Kiley, J., Sumstad, D., Kadidlo, D., Crist, S. B., Norris, B., Ahlquist, A., Hocum Stone, L. L., Everett, J., Shappa Faustich, J., Seelig, D., Rangarajan, P., Kim, H., Flory, C., Bushman, F., Ramachandran, S., Kang, P. B., Schumacher, R. J. & Wagner, J. E. & 4 others, , Oct 1 2025, In: Molecular Therapy. 33, 10, p. 5099-5117 19 p.Research output: Contribution to journal › Article › peer-review
Open Access5 Link opens in a new tab Scopus citations